Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors
Authors
Keywords
Cancer immunotherapy, Immune-related adverse events, Human leukocyte antigen, Therapeutic marker, Non–small cell lung cancer, Melanoma
Journal
EUROPEAN JOURNAL OF CANCER
Volume 107, Issue -, Pages 8-14
Publisher
Elsevier BV
Online
2018-12-07
DOI
10.1016/j.ejca.2018.11.009

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.